Novotech Acquires US-based Drug Development Consulting Firm, CBR International
Expands Drug Development and FDA Regulatory Expertise
Novotech, the leading Asia Pacific-centered biotech CRO today announced the acquisition of CBR International, a global product...
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in...
HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage biopharmaceutical company developing novel multifunctional therapies for metabolic and digestive diseases, today announced the dosing of...
Avance Clinical Celebrates GlobalReady Success as more than 40 Biotech Clients Enter Program
More than 40 biotech clients are now taking advantage of Avance Clinical's GlobalReady program which delivers streamlined clinical development from early phase in Australia...
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and...
Global biopharmaceutical company focusing on metabolic and digestive diseases
Proceeds to fund clinical and business development
HighTide Therapeutics Inc. (HighTide), a globally integrated clinical-stage...
Novotech is Gold Sponsor at Biotech Showcase 2023
Novotech, the Asia Pacific centered biotech specialist CRO is proud to be Gold Sponsor at Biotech Showcase 2023. Novotech CEO Dr. John Moller and...
Data Shows 50% of New Trials Have Sites in Asia Pacific
Novotech, the Asia Pacific centered biotech specialist CRO said the latest industry research publication by GlobalData and Novotech found almost 50% of new trials...
Preventing Strokes and Heart Attacks Doesn’t Have to Come with the Risk of Life-threatening...
Verseon is delighted to announce that the European Journal of Medicinal Chemistry has published a paper (www.sciencedirect.com/science/article/abs/pii/S0223523422007577) describing the company's groundbreaking research that led to...
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in...
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Frost & Sullivan Company of the Year Award 2022 for Best Practices...
Novotech Chairs BioCentury Summit Workshop on How to Build and Finance an East-West MRCT...
Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech's Chief Commercial Officer Barry Murphy is Session Chair...
Clinical Research Opportunities in China and the Path to USFDA Approval – Whitepaper
Novotech, the leading Asia Pacific biotech specialist CRO, and GlobalData have published the latest China biotech landscape analysis with expert guidance on pathways to...
AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, recently acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, announced today new...
The Biotech Landscape Webinar: Market Trends, Priorities, Predictions, and Pathways to FDA Approval
Novotech, the leading Asia Pacific biotech specialist CRO, and Endpoints News present a webinar for biotechs considering the clinical research opportunities in Asia Pacific...
Novotech India Recognised as “Best Workplaces for Women 2022” by Global Work Standards Authority
Novotech, the leading Asia Pacific biotech specialist CRO, has again received Best Workplace certification by the leading workplace culture organization Great Place to Work...
Novotech Selected as Scrip Awards Finalist for Best Full-Service CRO
Novotech, the leading Asia Pacific biotech specialist CRO, joins a prestigious group of global CROs as a finalist in the Scrip Award for Best...
Avance Clinical Wins International Health Award for Biotech CRO Services
Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier's Export Awards - International Health category. The award...
Agilis Robotics Targeting its Pre-B Round Fund-raising to be Completed by 2022
Successful In Vivo Testing Clears the Way for First Human Trial in Near Future
HONG KONG, Sept 22, 2022 - (ACN Newswire) - Agilis Robotics Limited (Agilis Robotics or...
Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene...
Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell &...
Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech...
Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in...
Meet the team at Booth #409
Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new data showing Asia...
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in...
